IV-delivered therapy for canine OA advances toward FDA approvalMay 7, 2026A study of intravenous uterine-derived mesenchymal stromal cells (UMSCs) in dogs with “naturally occurring OA” reportedly shows improvements in pain and mobility, with no serious treatment-related adverse events.
SPONSORED CONTENTSwitch to Triple Protection in One Monthly DoseSee the difference of triple protection with the one monthly chew. + Learn More